#KrystalBiotech Receives #FDAPlatformTechnologyDesignation for HSV-1 Viral Vector Used in KB801 for the Treatment of #NeurotrophicKeratitis
KB801 has the potential to significantly reduce treatment burden & maintain consistent NGF levels.
www.biospace.com/press-releas...
KB801 has the potential to significantly reduce treatment burden & maintain consistent NGF levels.
www.biospace.com/press-releas...
Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis
www.biospace.com
October 15, 2025 at 6:08 PM
#KrystalBiotech Receives #FDAPlatformTechnologyDesignation for HSV-1 Viral Vector Used in KB801 for the Treatment of #NeurotrophicKeratitis
KB801 has the potential to significantly reduce treatment burden & maintain consistent NGF levels.
www.biospace.com/press-releas...
KB801 has the potential to significantly reduce treatment burden & maintain consistent NGF levels.
www.biospace.com/press-releas...
RBC Capital initiated Krystal Biotech at Outperform with a $400 price target, projecting blockbuster potential for both Vyjuvek and pipeline candidate KB801.
#KrystalBiotech #KRYS #GeneTherapy #Biotech #Vyjuvek
#KrystalBiotech #KRYS #GeneTherapy #Biotech #Vyjuvek
August 17, 2026 at 11:31 AM
RBC Capital initiated Krystal Biotech at Outperform with a $400 price target, projecting blockbuster potential for both Vyjuvek and pipeline candidate KB801.
#KrystalBiotech #KRYS #GeneTherapy #Biotech #Vyjuvek
#KrystalBiotech #KRYS #GeneTherapy #Biotech #Vyjuvek
Farmaci, Prix Galien Italia a Krystal Biotech per la prima terapia genica in una malattia rara ... LEGGI TUTTO #Farmaci #PrixGalien #KrystalBiotech #TerapiaGenica #MedicinaAvanzata
Farmaci, Prix Galien Italia a Krystal Biotech per la prima terapia genica in una malattia rara
(Adnkronos) - Krystal Biotech ha annunciato di aver ricevuto il prestigioso Prix Galien Italia 2025 nella categoria Medicinali per terapia avanzata (Atmp) per Vyjuvek® (beremagene geperpavec o B-vec), la prima e unica terapia genica ap...
dlvr.it
October 15, 2025 at 10:29 AM
Farmaci, Prix Galien Italia a Krystal Biotech per la prima terapia genica in una malattia rara ... LEGGI TUTTO #Farmaci #PrixGalien #KrystalBiotech #TerapiaGenica #MedicinaAvanzata
FDA approves first treatment for skin condition that causes persistent wounds, a redosable gene therapy
#aaronowens #vyjuvek #krystalbiotech
➡️ Now on https://biztoc.com — https://www.statnews.com/2023/05/19/vyjuvek-krystal-gene-therapy-for-dystrophic-epidermolysis-bullosa/
#aaronowens #vyjuvek #krystalbiotech
➡️ Now on https://biztoc.com — https://www.statnews.com/2023/05/19/vyjuvek-krystal-gene-therapy-for-dystrophic-epidermolysis-bullosa/
May 21, 2023 at 11:28 AM
FDA approves first treatment for skin condition that causes persistent wounds, a redosable gene therapy
#aaronowens #vyjuvek #krystalbiotech
➡️ Now on https://biztoc.com — https://www.statnews.com/2023/05/19/vyjuvek-krystal-gene-therapy-for-dystrophic-epidermolysis-bullosa/
#aaronowens #vyjuvek #krystalbiotech
➡️ Now on https://biztoc.com — https://www.statnews.com/2023/05/19/vyjuvek-krystal-gene-therapy-for-dystrophic-epidermolysis-bullosa/